文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

鼻胃管途径粪菌移植治疗暴发性感染:1例报告

Nasogastric Delivery of Fecal Microbiota Transplantation for the Treatment of Fulminant Infection: A Case Report.

作者信息

Singh Amitjeet, Young Edward, Maurya Aashish, Rajagopalan Arvind

机构信息

Department of Medicine Lyell McEwin Hospital Elizabeth South Australia Australia.

Department of Gastroenterology Lyell McEwin Hospital Elizabeth South Australia Australia.

出版信息

JGH Open. 2025 May 13;9(5):e70177. doi: 10.1002/jgh3.70177. eCollection 2025 May.


DOI:10.1002/jgh3.70177
PMID:40371237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12075926/
Abstract

INTRODUCTION: Clostridioides difficile infection (CDI) is a significant cause of antibiotic-associated diarrhea with high morbidity and mortality, particularly in cases of fulminant disease. Fecal microbiota transplantation (FMT) has demonstrated efficacy in treating severe and refractory CDI, typically administered via colonoscopy. However, in cases complicated by toxic megacolon, alternative methods of FMT delivery may be necessary. CASE REPORT: This case report describes a 46-year-old female with cirrhosis and fulminant CDI complicated by toxic megacolon. Due to the patient's hemodynamic instability and contraindications to endoscopic FMT delivery, a novel approach of nasogastric FMT administration was utilized. The patient received a combination of enema-delivered and nasogastric FMT alongside standard antibiotic therapy. This approach resulted in rapid clinical improvement, with resolution of toxic megacolon, normalization of inflammatory markers, and avoidance of colectomy. DISCUSSION: This report highlights the successful use of nasogastric FMT in a patient with fulminant CDI, offering a potential alternative delivery route when colonoscopic administration is contraindicated. To our knowledge, this is the first reported case of nasogastric FMT successfully resolving -associated toxic megacolon.

摘要

引言:艰难梭菌感染(CDI)是抗生素相关性腹泻的一个重要病因,发病率和死亡率都很高,尤其是在暴发性疾病的病例中。粪便微生物群移植(FMT)已被证明在治疗严重和难治性CDI方面有效,通常通过结肠镜检查进行。然而,在并发中毒性巨结肠的情况下,可能需要其他FMT递送方法。 病例报告:本病例报告描述了一名46岁患有肝硬化且暴发性CDI并发中毒性巨结肠的女性。由于患者血流动力学不稳定以及内镜下FMT递送存在禁忌证,采用了一种新的鼻胃管FMT给药方法。患者在接受标准抗生素治疗的同时,接受了灌肠和鼻胃管FMT联合治疗。这种方法使临床症状迅速改善,中毒性巨结肠得到缓解,炎症标志物恢复正常,避免了结肠切除术。 讨论:本报告强调了鼻胃管FMT在暴发性CDI患者中的成功应用,为结肠镜给药禁忌时提供了一种潜在的替代递送途径。据我们所知,这是首例鼻胃管FMT成功解决相关中毒性巨结肠的病例报告。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1a6/12075926/ec24adef1445/JGH3-9-e70177-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1a6/12075926/ec24adef1445/JGH3-9-e70177-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1a6/12075926/ec24adef1445/JGH3-9-e70177-g001.jpg

相似文献

[1]
Nasogastric Delivery of Fecal Microbiota Transplantation for the Treatment of Fulminant Infection: A Case Report.

JGH Open. 2025-5-13

[2]
Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).

Cochrane Database Syst Rev. 2023-4-25

[3]
Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.

Dig Dis Sci. 2022-3

[4]
Fecal Microbiota Transplantation for Fulminant Clostridioides Difficile Infection: A Combined Medical and Surgical Case Series.

Cureus. 2023-2-14

[5]
Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.

Cas Lek Cesk. 2022

[6]
Fecal Microbiota Transplantation: Redefining Surgical Management of Refractory Infection.

Clin Colon Rectal Surg. 2020-3

[7]
Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis.

Am J Health Syst Pharm. 2021-7-22

[8]
Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection.

Clin Gastroenterol Hepatol. 2020-9

[9]
Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis.

Dig Dis Sci. 2021-2

[10]
Fecal Microbiota Transplantation.

Clin Colon Rectal Surg. 2023-1-25

本文引用的文献

[1]
Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).

Cochrane Database Syst Rev. 2023-4-25

[2]
Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.

BMC Infect Dis. 2021-5-19

[3]
Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection.

Aliment Pharmacol Ther. 2017-9

[4]
The incidence and drug resistance of Clostridium difficile infection in Mainland China: a systematic review and meta-analysis.

Sci Rep. 2016-11-29

[5]
Understanding the mechanisms of faecal microbiota transplantation.

Nat Rev Gastroenterol Hepatol. 2016-6-22

[6]
Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand.

Intern Med J. 2016-4

[7]
A case of toxic megacolon caused by clostridium difficile infection and treated with fecal microbiota transplantation.

Gut Liver. 2015-3

[8]
Fecal Transplant for Treatment of Toxic Megacolon Associated With Clostridium Difficile Colitis in a Patient With Duchenne Muscular Dystrophy.

Am J Ther. 2016

[9]
Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium difficile infection: a review and pooled analysis.

Infection. 2012-7-31

[10]
Effectiveness of an aspiration risk-reduction protocol.

Nurs Res. 2010

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索